Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of SEK 28.16 billion. The enterprise value is 29.29 billion.

Market Cap	28.16B
Enterprise Value	29.29B

Important Dates

The next estimated earnings date is Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Vitrolife AB has 135.39 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	n/a
Shares Outstanding	135.39M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	75.26%
Float	74.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	37.95
PS Ratio	7.92
PB Ratio	2.14
P/TBV Ratio	n/a
P/FCF Ratio	40.17
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.68, with an EV/FCF ratio of 41.78.

EV / Earnings	-7.70
EV / Sales	8.24
EV / EBITDA	24.68
EV / EBIT	37.94
EV / FCF	41.78

Financial Position

The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.16.

Current Ratio	2.91
Quick Ratio	2.26
Debt / Equity	0.16
Debt / EBITDA	1.73
Debt / FCF	2.92
Interest Coverage	14.57

Financial Efficiency

Return on equity (ROE) is -24.89% and return on invested capital (ROIC) is 2.77%.

Return on Equity (ROE)	-24.89%
Return on Assets (ROA)	2.54%
Return on Capital (ROIC)	2.77%
Revenue Per Employee	3.20M
Profits Per Employee	-3.42M
Employee Count	1,123
Asset Turnover	0.19
Inventory Turnover	3.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.93% in the last 52 weeks. The beta is 1.78, so Vitrolife AB's price volatility has been higher than the market average.

Beta (5Y)	1.78
52-Week Price Change	+10.93%
50-Day Moving Average	227.14
200-Day Moving Average	209.76
Relative Strength Index (RSI)	37.32
Average Volume (20 Days)	102,510

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of SEK 3.56 billion and -3.81 billion in losses. Loss per share was -28.10.

Revenue	3.56B
Gross Profit	2.07B
Operating Income	772.00M
Pretax Income	-3.64B
Net Income	-3.81B
EBITDA	1.16B
EBIT	772.00M
Loss Per Share	-28.10

Full Income Statement

Balance Sheet

The company has 925.00 million in cash and 2.05 billion in debt, giving a net cash position of -1.13 billion or -8.31 per share.

Cash & Cash Equivalents	925.00M
Total Debt	2.05B
Net Cash	-1.13B
Net Cash Per Share	-8.31
Equity (Book Value)	13.14B
Book Value Per Share	97.03
Working Capital	1.39B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 811.00 million and capital expenditures -110.00 million, giving a free cash flow of 701.00 million.

Operating Cash Flow	811.00M
Capital Expenditures	-110.00M
Free Cash Flow	701.00M
FCF Per Share	5.18

Full Cash Flow Statement

Margins

Gross margin is 58.17%, with operating and profit margins of 21.72% and -107.03%.

Gross Margin	58.17%
Operating Margin	21.72%
Pretax Margin	-102.36%
Profit Margin	-107.03%
EBITDA Margin	32.49%
EBIT Margin	21.72%
FCF Margin	19.72%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.48%.

Dividend Per Share	1.00
Dividend Yield	0.48%
Dividend Growth (YoY)	17.65%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	0.47%
Earnings Yield	-13.51%
FCF Yield	2.49%

Dividend Details

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Vitrolife AB has an Altman Z-Score of 4.4.

Altman Z-Score	4.4
Piotroski F-Score	n/a